Will Evommune stock go up?

According to Danelfin AI, Evommune has today an AI Score of 7/10 (Buy rating), because its probability of beating the market in 3 months (57.81%) is +6.99% vs. the average probability (50.82%) of all US-listed stocks.

What is the target price for Evommune stock?

The Evommune target price is $12.97 (1Y), according to the average price target offered by analysts.

Is it a good time to buy, sell, or hold Evommune stock right now?

Evommune has today a Buy rating (AI Score 7/10), according to Danelfin AI. Its probability of beating the market in 3 months (57.81%) is +6.99% vs. the average probability (50.82%) of all US-listed stocks, based on our AI-powered analysis. You can find more details on whether Evommune stock is a good buy .

Is Evommune undervalued right now?

Based on analysts, the average price target downside for Evommune is 0.00% (1Y). According to Danelfin AI, Evommune has today an AI Score of 7/10 (Buy Rating).

What was the price range of Evommune stock over the past 12 months?

The Evommune stock price range over the past 12 months has been - - -.

What is going on with Evommune stock in the last 3 months?

The Evommune stock performance in the last quarter has been -42.14%.

Does Evommune offer dividend payments?

No, Evommune does not currently pay dividends.

What is the current market capitalization of Evommune?

Evommune's market cap is $466.8M, as of 2026-07-03 08:00.

Evommune Inc (EVMN) AI Stock Analysis

Advanced Chart

Custom range

Jul 3, 2025

→

Jul 3, 2026

Custom range

Jul 3, 2025

→

Jul 3, 2026

EVMN AI-Powered Stock Analysis

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

Valuation+4.17%
How the stock is priced relative to its fundamentals
Sentiment+1.77%
How analysts and the market view the stock
Earnings Quality+0.94%
Stability and reliability of reported earnings
Momentum+0.86%
Direction and strength of recent price movements
Growth+0.34%
Expected pace of revenue and earnings expansion
Size & Liquidity+0.32%
Company size and trading liquidity

Volatility-1.43%
How much the stock price tends to fluctuate

EVMN probability advantage of beating the market (3M):

+6.99%

AI Score

Buy

Evommune (EVMN) has an AI Score of 7/10 (Buy) because, according to an overall analysis, it has a probability advantage of +6.99% of beating the market (S&P500) in the next 3 months. This advantage is calculated as the difference between the average probability of any US-listed stock (50.82%) and the probability of EVMN (57.81%) of outperforming the market in the next 3 months, as determined by Danelfin AI’s comprehensive analysis.

Average probability of any US-listed stock of beating the market (3M)50.82%
EVMN probability advantage of beating the market (3M)+6.99%
EVMN probability of beating the market (3M)57.81%

EVMN probability advantage of beating the market (3M): +6.99%

The AI-powered overall analysis of Evommune (EVMN) is based on the 24 fundamental, technical, and sentiment features that had the greatest impact on stock performance during the last 12 months (alpha signals). These alpha signals explain the probability advantage of EVMN:

Type	Alpha Signal	Current Value	Value Decile Position	Probability Advantage Impact (3M)
Fundamental	Fundamentals Impact (Long Tail)	-	N/A	+4.04%
Fundamental	Operating Cash Flow (Qtr Discrete)	-27.5		+1.76%
Sentiment	Industry (GICS)	Biotechnology	N/A	+1.25%
Fundamental	Sloan Ratio	0.28		-0.81%
Technical	ATR (14d Volatility)	2.07		-0.72%
Technical	Maximum Volatility	8.77%		-0.70%
Sentiment	Fear & Greed Index (CNN)	31	N/A	-0.64%
Sentiment	Institutional Ownership	59.87%		+0.59%
Technical	Performance (YTD)	-0.24%		+0.52%
Fundamental	Tangible Shareholders' Equity	304.55		+0.46%
Sentiment	Upgrade to unlock			+0.44%
Sentiment	Upgrade to unlock			+0.40%
Technical	Upgrade to unlock			-0.38%
Technical	Upgrade to unlock			+0.35%
Technical	Upgrade to unlock			-0.35%

Rest of Alpha Signals: +0.79%

EVMN probability advantage of beating the market (3M)Total:+6.99%
EVMN AI Score

Significant changes Vs previous day

EVMN Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

Entry:$12.97
Horizon: 3 months
Stop Loss:$XXXXXPro (XXXXXPro) or AI Score < 7/10
Take Profit:$XXXXXPro (XXXXX
Pro
) or AI Score < 7/10

EVMN Proven Buy Signal & Price Forecast

This is the price chart for EVMN from January 2, 2026 until today. The chart indicates, in green, the 13 days when the stock received a Buy/Strong Buy rating (buy signals, AI Score 7 to 10).

Forecast: In the section below, the central dotted line represents the most expected path, while the shaded area indicates the anticipated price range. This is based on previous Buy signals with a 90% confidence level.

Full Track Record

Unlock AI-powered forecast

Closing price (USD)
Buy signals

Forecast:

1 Month
3 Months
6 Months
1 Year

EVMN Average Past Performance & Win Rate

Three months after its 9 Buy signals since July 2026, EVMN had an average performance of xxxxx and a xxxxx Win rate (positive performance).

9 Past EVMN Buy Signals	1 Month Later	3 Months Later	6 Months Later	1 Year Later
Average Performance				0.00%
Average Alpha				0.00%
Win Rate (% Positive Perf.)				0.00%
% Positive Alpha				0.00%

EVMN Frequently Asked Questions

Will Evommune stock go up?
According to Danelfin AI, Evommune has today an AI Score of 7/10 (Buy rating), because its probability of beating the market in 3 months (57.81%) is +6.99% vs. the average probability (50.82%) of all US-listed stocks.
What is the target price for Evommune stock?
Is it a good time to buy, sell, or hold Evommune stock right now?
Is Evommune undervalued right now?
What was the price range of Evommune stock over the past 12 months?
What is going on with Evommune stock in the last 3 months?
Does Evommune offer dividend payments?
What is the current market capitalization of Evommune?

Evommune Inc Company Profile

Evommune Inc (EVMN) is a biotechnology company focused on developing novel therapeutics for inflammatory and autoimmune diseases. The company targets unmet medical needs in areas with significant patient populations and limited treatment options. Its primary customers are patients and healthcare providers seeking advanced treatment modalities. Evommune's core domain involves the research and development of biologics. This includes the creation of antibody-based therapies designed to modulate specific immune pathways. The company's pipeline aims to address conditions such as rheumatoid arthritis and other chronic inflammatory disorders. Evommune's platform leverages advanced protein engineering and immunology expertise. It focuses on developing therapies that offer improved efficacy and safety profiles compared to existing treatments. The company's approach involves rigorous preclinical testing and clinical trials to advance its drug candidates. Evommune's revenue model is based on the development and potential commercialization of its drug candidates through licensing agreements or direct sales. The company's go-to-market strategy will likely involve partnerships with pharmaceutical companies and direct engagement with the medical community. Its global reach will be established through regulatory approvals and commercialization efforts in key pharmaceutical markets.

Sector:Health Care
Country:United States
Industry:Biotechnology
Address:1841 Page Mill Road Suite 100, Palo Alto
Employees:48
Website:evommune.com

Pros

Proprietary drug candidate pipeline in immunology

Potential for high pricing power for novel therapies

High patient switching costs for effective treatments

Global addressable market for chronic inflammatory diseases

Robust discovery engine for immunology targets

Cons

Extremely high capital intensity for drug development

Low probability of clinical trial success for candidates

Extensive regulatory approval timelines for new drugs

Future intellectual property expiry risk for approved drugs

Dependence on external funding for ongoing operations

Company	AI Score	Compare
IMUXImmunic Inc
IMNMImmunome Inc
INMBINmune Bio Inc
IMVTImmunovant Inc
EVAXEvaxion A/S

Company	AI Score	Compare
IMUXImmunic Inc
IMNMImmunome Inc
INMBINmune Bio Inc
IMVTImmunovant Inc
EVAXEvaxion A/S

EVMN Stock AI Analysis High Risk

Evommune Inc

EVMN Stock AI Analysis

Evommune Inc

EVMN AI-Powered Stock Analysis

AI Score Explanation

Generating AI Score explanation

AI Score Explanation

Generating AI Score explanation

AI Score Alpha Factors

Alpha Signals: What Drives the AI Score

EVMN probability advantage of beating the market (3M): +6.99%

EVMN Trading Parameters

EVMN Proven Buy Signal & Price Forecast

EVMN Average Past Performance & Win Rate

EVMN Frequently Asked Questions

Will Evommune stock go up?

What is the target price for Evommune stock?

Is it a good time to buy, sell, or hold Evommune stock right now?

Is Evommune undervalued right now?

What was the price range of Evommune stock over the past 12 months?

What is going on with Evommune stock in the last 3 months?

Does Evommune offer dividend payments?

What is the current market capitalization of Evommune?

Evommune Inc Company Profile

Pros

Cons

Pros

Cons

EVMN Company Profile Summary

EVMN Related Investment Themes

EVMN Related Stocks

EVMN Top 10 Industry Stocks

Biotechnology

EVMN Top 10 Sector Stocks

Health Care

EVMN Stock AI Analysis High Risk

Evommune Inc

NEW YORK STOCK EXCHANGE, INC.

Will Evommune stock go up?

What is the target price for Evommune stock?

Is it a good time to buy, sell, or hold Evommune stock right now?

Is Evommune undervalued right now?

What was the price range of Evommune stock over the past 12 months?

What is going on with Evommune stock in the last 3 months?

Does Evommune offer dividend payments?

What is the current market capitalization of Evommune?

NEW YORK STOCK EXCHANGE, INC.

EVMN Proven Buy Signal & Price Forecast

Pros

Cons

AI Score Explanation

Generating AI Score explanation